QuidelOrtho Corporation
QDEL
$2.16 (10.89%)
1D
1W
3M
1Y
5Y
ALL
QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 5 days ago • QDEL
QuidelOrtho Q3 Earnings and Revenues Beat Estimates, Margins Expand
Seeking Alpha • 6 days ago • QDEL
QuidelOrtho Corporation (QDEL) Q3 2025 Earnings Call Transcript
PRNewsWire • 6 days ago • QDEL
QuidelOrtho Reports Third Quarter 2025 Financial Results
PRNewsWire • 9 days ago • QDEL
QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay
PRNewsWire • 19 days ago • QDEL
Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.